British alternative milk manufacturer Rude Health has been acquired by Finnish food company Oddlygood, a spin-off from dairy powerhouse Valio, in a strategic move that positions both firms for significant market expansion.
The deal, which concluded just ahead of anticipated capital gains tax increases in the upcoming budget, will result in a seven-figure windfall for co-founder Camilla Barnard. The transaction marks the culmination of a two-year negotiation process, though specific financial terms remain undisclosed. Rude Health’s most recent financial reports showed impressive revenues of £23.8 million, with pre-tax profits reaching £100,000.
Known predominantly for its plant-based milk alternatives, including almond, oat, and hazelnut varieties, Rude Health has established itself as a prominent player in the UK’s alternative dairy sector. These products constitute 80% of the company’s total sales, complementing their range of cereals, mueslis, and healthy snacks.
The acquisition presents significant synergistic opportunities, with Oddlygood’s strong presence in yoghurts and desserts across Nordic and Eastern European markets complementing Rude Health’s established product portfolio. The British company’s workforce of 30 employees will remain unchanged in the immediate term, with operations continuing from their UK base.
Tim Smith, who assumed the role of chief executive in November 2021, will continue to lead the organisation under its new ownership. The deal also benefits approximately 30 current and former employees who hold minority stakes in the business.
Ms Barnard, who founded the company in 2005 with her ex-husband Nick Barnard, will transition to a consultancy role with Oddlygood, maintaining involvement while pursuing personal interests. The combined entity is expected to leverage Valio’s extensive research and development capabilities to drive future innovation and growth.
Post Disclaimer
The following content has been published by Stockmark.IT. All information utilised in the creation of this communication has been gathered from publicly available sources that we consider reliable. Nevertheless, we cannot guarantee the accuracy or completeness of this communication.
This communication is intended solely for informational purposes and should not be construed as an offer, recommendation, solicitation, inducement, or invitation by or on behalf of the Company or any affiliates to engage in any investment activities. The opinions and views expressed by the authors are their own and do not necessarily reflect those of the Company, its affiliates, or any other third party.
The services and products mentioned in this communication may not be suitable for all recipients, by continuing to read this website and its content you agree to the terms of this disclaimer.